Clinical Trial

Safety and Efficacy of Autologous Adipose-derived Mesenchymal Stem Cells Therapy in Adults With Atrophic Scars

Not Yet Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
The purpose of this clinical trial was to evaluate the safety and efficacy of a single administration of TRTP-101 in adults with atrophic scars.
Trial Details
NCT Number NCT07474467
Lead Sponsor CellinCells
Conditions Atrophic Scar
Enrollment 31 participants
Start Date 2026-08-01
Primary Completion 2029-02-01 (estimated)
Study Completion 2029-08-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-16